
Digital therapies (DTx) are software-based treatments that help prevent, manage, or treat a medical condition. In simple terms, DTx are patient-focused apps that assist people in handling their health issues and have been shown to be effective.
Cuviva acquired ScientificMed in 2021. ScientificMed has been developing digital therapies since 2012, which are offered on Cuviva’s medical platform.
Cuviva currently offers two validated digital therapies:
Both are approved for use (MDR).
Current Research:
Research is ongoing with Linköping University and Karolinska Institute. Several DTx are being tested in clinical studies, including mBrace.
Read more about HealthyMoms here and MINISTOP here.
Implementation research is currently underway in collaboration with Linköping University and the Karolinska Institute.
Several digital therapies (DTx) are being evaluated in clinical studies today. For example, you can read about mBrace, which is currently undergoing validation.